N2-{[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,4-dihydropyridin-2-yl]methyl}-N-methyl-L-alaninamide | 1259499-27-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N2-{[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,4-dihydropyridin-2-yl]methyl}-N-methyl-L-alaninamide
• 英文别名: (2S)-2-[[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)pyridin-2-yl]methylamino]-N-methylpropanamide
• CAS: 1259499-27-8
• 化学式: C₁₃H₁₈F₃N₃O₄
• 分子量: 337.299
• InChiKey: QBDVLXOFEXYGNQ-OCAOPBLFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  102
• 氢给体数：
  4
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  (S)-2-((5-(benzyloxy)-1-methyl-4-oxo-1,4-dihydropyridin-2-yl)methylamino)-N-methylpropanamide 在 palladium 10% on activated carbon 氢气 、 potassium carbonate 作用下， 以 甲醇 、 乙腈 为溶剂， 75.0~80.0 ℃ 、344.75 kPa 条件下， 反应 2.0h， 生成 N2-{[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,4-dihydropyridin-2-yl]methyl}-N-methyl-L-alaninamide
  参考文献：
  名称：

  [EN] FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES
  [FR] DÉRIVÉS FLUORÉS DE 3-HYDROXYPYRIDIN-4-ONES

  摘要：

  提供的是Formula I的化合物，它们是3-羟基吡啶-4-酮的衍生物。这些化合物可用于治疗与铁的毒性浓度有关的医疗状况。这些化合物可用于制备用于治疗与铁的毒性浓度有关的医疗状况的药物。与铁的毒性浓度有关的医疗状况可从以下组中选择：癌症、肺部疾病、进行性肾病和弗里德里希共济失调。

  公开号：

  WO2011000104A1
• 作为试剂：
  描述：

  (S)-2-((5-hydroxy-1-methyl-4-oxo-1,4-dihydropyridin-2-yl)methylamino)-N-methylpropanamide 、 三氟乙醛缩甲基半醇 、 potassium carbonate 、 ammonium hydroxide 在 三氟乙醛缩甲基半醇 、 silica gel 、 甲醇 、 乙酸乙酯 、 10 、 N2-{[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,4-dihydropyridin-2-yl]methyl}-N-methyl-L-alaninamide 作用下， 以 乙腈 、 异丙醇 为溶剂， 反应 40.0h， 以Thus, the title compound N2-{[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,4-dihydropyridin-2-yl]methyl}-N-methyl-L-alaninamide, Apo7033, was obtained as a yellowish solid (1.53 g) in 35% yield的产率得到N2-{[5-hydroxy-1-methyl-4-oxo-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,4-dihydropyridin-2-yl]methyl}-N-methyl-L-alaninamide
  参考文献：
  名称：

  FLUORINATED DERIVATES OF 3-HYDROXYPYRIDIN-4-ONES

  摘要：

  提供的是公式I的化合物，它们是3-羟基吡啶-4-酮的衍生物。这些化合物可以用于治疗与铁的毒性浓度相关的医疗状况。这些化合物可以用于制备治疗与铁的毒性浓度相关的医疗状况的药物。与铁的毒性浓度相关的医疗状况可以从以下组中选择：癌症、肺部疾病、进行性肾脏疾病和弗里德里希共济失调症。

  公开号：

  US20120270882A1

文献信息

• Fluorinated derivates of 3-hydroxypyridin-4-ones
  申请人：Tam Tim Fat

  公开号：US09073865B2

  公开（公告）日：2015-07-07

  Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia.

  提供的化合物为公式I的衍生物，属于3-羟基吡啶-4-酮类。这些化合物可用于治疗与铁毒性浓度相关的医疗状况。这些化合物可用于制备治疗与铁毒性浓度相关的医疗状况的药物。与铁毒性浓度相关的医疗状况可以从以下一组中选择：癌症、肺部疾病、进行性肾脏疾病和弗雷德里希共济失调症。
• FLUORINATED DERIVATIVES OF 3-HYDROXYPYRIDIN-4-ONES
  申请人：APOTEX TECHNOLOGIES INC.

  公开号：US20150335626A1

  公开（公告）日：2015-11-26

  Provided are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia.

  提供的是I式化合物，它们是3-羟基吡啶-4-酮的衍生物。这些化合物可用于治疗与铁的毒性浓度相关的医疗状况。这些化合物可用于制备治疗与铁的毒性浓度相关的医疗状况的药物。与铁的毒性浓度相关的医疗状况可从以下组中选择：癌症，肺部疾病，进行性肾脏疾病和弗里德里希共济失调症。
• Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones
  申请人：Apotex Technologies Inc.

  公开号：US20160083346A1

  公开（公告）日：2016-03-24

  Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.

  公式I的衍生物化合物是3-羟基吡啶-4-酮的衍生物。这些化合物可用于治疗与铁的毒性浓度相关的医疗状况。这些化合物可用于制备治疗与铁的毒性浓度相关的医疗状况的药物。与铁毒性浓度相关的医疗状况可以从以下组中选择：癌症、肺病、进行性肾病和弗里德赫氏共济失调。
• "Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones"
  申请人：Apotex Technologies Inc.

  公开号：US20170247329A1

  公开（公告）日：2017-08-31

  Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.
• US9073865B2
  申请人：——

  公开号：US9073865B2

  公开（公告）日：2015-07-07